Sofosbuvir and velpatasvir and Hepatic impairment
Result of checking the interaction of drug Sofosbuvir and velpatasvir and disease Hepatic impairment for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Sofosbuvir is extensively metabolized in the liver. The safety and efficacy of sofosbuvir as a single agent have not been established in patients with decompensated cirrhosis. No dosage adjustment is required for patients with mild, moderate or severe hepatic impairment (Child-Pugh Class A, B or C).
Generic Name: sofosbuvir / velpatasvir
Brand Name: Epclusa
Synonyms: Sofosbuvir and Velpatasvir
Sofosbuvir and velpatasvir - zaburzenia czynności wątroby 
Sofosbuvir and velpatasvir - insuficiência hepática 
Sofosbuvir and velpatasvir - gangguan hati 
Sofosbuvir and velpatasvir - gangguan hati 
Sofosbuvir and velpatasvir - insufficienza epatica 
Sofosbuvir and velpatasvir - insuffisance hépatique 
Sofosbuvir and velpatasvir - Leberfunktionsstörung 
Sofosbuvir and velpatasvir - deterioro hepático 
Sofosbuvir and velpatasvir - печеночная недостаточность 
Sofosbuvir and velpatasvir - karaciğer yetmezliği 
Sofosbuvir and velpatasvir - اختلال كبدي 
Sofosbuvir and velpatasvir - 肝功能不全